Picture supply: The Motley Idiot.
Align Technology (ALGN)
Q3 2022 Earnings Name
Oct 26, 2022, 4:30 p.m. ET
Contents:
- Ready Remarks
- Questions and Solutions
- Name Contributors
Ready Remarks:
Operator
Greetings. Welcome to the Align Q3 2022 earnings name. At the moment, all individuals are in a hear mode solely. An issue-and-answer session will observe the formal presentation.
Please be aware this convention is being recorded. I might now like to show the convention over to our host, Shirley Stacy, with Align Technology. Chances are you’ll start.
Shirley Stacy — Vice President, Company Communications and Investor Relations
Good afternoon, and thanks for becoming a member of us. I am Shirley Stacy, vice chairman of company communications and investor relations. Becoming a member of me for right this moment’s name is Joe Hogan, president and CEO; and John Morici, CFO. We issued third-quarter 2022 monetary outcomes right this moment through Enterprise Wire, which is accessible on our web site at investor.aligntech.com.
At present’s convention name is being audio webcast and will probably be archived on our web site for roughly one month. A phone replay will probably be out there right this moment by roughly 5:30 p.m. Jap Time by 5:30 p.m. Jap Time on November 9.
To entry the phone replay, home callers ought to dial 866-813-9403 with entry code 119351. Worldwide callers ought to dial 929-458-6194 utilizing the identical entry code. As a reminder, the data supplied and mentioned right this moment will embody forward-looking statements, together with statements about Align’s future occasions and product outlook. These forward-looking statements are solely predictions and contain dangers and uncertainties and which might be described in additional element in our most up-to-date periodic experiences filed with the Securities and Alternate Fee out there on our web site and at sec.gov.
Precise outcomes could differ considerably, and Align expressly assumes no obligation to replace any forward-looking statements. We now have posted historic monetary statements, together with the corresponding reconciliations, together with our GAAP to non-GAAP reconciliations, if relevant, and our third quarter 2022 convention name slides on our web site below quarterly outcomes. Please refer to those recordsdata for extra detailed data. And with that, I would like to show the decision over to Align Technology’s president and CEO, Joe Hogan.
Joe?
Joe Hogan — President and Chief Government Officer
Thanks, Shirley. Good afternoon, and thanks for becoming a member of us. On our name right this moment, I will present an summary of our Q3 outcomes and talk about the efficiency of our two working segments, System and Companies and Clear Aligners. John will present extra element on our monetary efficiency and our view for the rest of the 12 months.
Following that, I will come again, summarize a number of key factors, and open the decision to questions. Our third-quarter outcomes replicate the continued macroeconomic uncertainty and weaker client confidence, in addition to vital impression from unfavorable overseas change charges throughout currencies that have an effect on our operations. On a constant-currency foundation, whole Q3 revenues have been decreased by $25 million or 2.7% sequentially and $57.4 million or 6.1% 12 months over 12 months, one of many largest quarterly overseas change impacts in our historical past. We stay assured within the execution of our strategic development drivers regardless of the persevering with financial headwinds.
In Q3, we reached our 14 millionth Invisalign affected person milestone throughout the quarter, which incorporates practically 4 million youngsters and youngsters as younger as six years outdated, who’ve been handled with Invisalign clear aligners. In Q3, teen case begins of 200,000 have been up 13% sequentially and simply off barely in comparison with Q3 ’21 a 12 months in the past with a document 206,000 youngsters began Invisalign remedy. We’re additionally excited to be launching considerably new merchandise and applied sciences that additional improve the Align Digital Platform, main the digital transformation are the apply of dentistry. Through the quarter, we additionally started to commercialize ClinCheck Dwell Replace software program, Invisalign Follow App, Invisalign Private Plan, Invisalign Smile Architect, the Invisalign End result Simulator Professional with in-face visualization, Cone Beam Computed Tomography with ClinCheck software program Invisalign, Digital AI software program, and iTero-exocad Connector.
These know-how developments symbolize an vital enlargement of our digital platform that we consider will assist our physician clients enhance remedy effectivity and ship superior medical outcomes and affected person experiences, positioning us to drive development when the market inevitably rebounds. We’ll be showcasing these improvements subsequent month on the Invisalign Ortho Summit, Las Vegas, the premier schooling, and networking expertise for Invisalign practices with essentially the most peer-to-peer displays of any Invisalign schooling occasion. By way of Q3, Techniques, and Companies, curiosity in our iTero scanners was good with elevated product demos throughout the areas. Medical doctors are more and more recognizing the substantial advantages of intraoral scanning and end-to-end digital workflows with the iTero scanner and imaging techniques.
On the similar time, growing inflation, rising rates of interest, and fewer affected person visitors and dental practices are lengthening gross sales cycles and conversion time. For Q3, System and Companies revenues of $157.5 million have been down sequentially 12 months over 12 months. On a constant-currency foundation, unfavorable overseas change decreased Q3 ’22 Techniques and Companies revenues by roughly $4.1 million or 2.5% sequentially and roughly $9.9 million or 5.9% 12 months over 12 months. For Q3, scanner providers year-over-year income development was sturdy throughout all area notably as a consequence of elevated subscription income pushed by development of the put in base of iTero scanners.
Yr-over-year development additionally displays elevated gross sales of iTero warranties and continued development of our scanner leasing rental packages. We proceed to work intently with our physician clients to assist their apply development and digital transformation targets. This contains understanding alternative ways to allow them to navigate to extra unsure financial surroundings. Over the previous 12 months, we have had good success rolling out new leasing packages in Latin America and licensed preowned or CPO, as we name it, choices in India and North America.
We’re additionally taking a look at new alternatives on the capital gear aspect for our DSO companions. This can be a pure development in an gear enterprise with a big and rising put in base. As we introduce new merchandise, there are extra alternatives for purchasers to improve to make trade-ins and to offer refurbished scanners for rising markets, too. We count on to proceed to roll out packages which might be particularly useful for purchasers within the present macroeconomic surroundings.
It is promoting the way in which medical doctors and clients need to do enterprise and leveraging our steadiness sheet. We’re nonetheless early, we’re happy with the contribution of margin accretion we’re seeing. For our Clear Aligner section, macroeconomic uncertainty and ready client confidence continues to impression the dental market general, making for a difficult working surroundings throughout the board. For Q3, third-party experiences point out there are fewer new affected person visits, much less visitors move and decrease orthodontic case begins general.
Our Clear Aligner volumes additional replicate the underlying orthodontic market traits and a shift away from adults towards teenagers in Q3. Q3 Clear Aligner revenues have been down 8.2% sequentially and down 12.5% 12 months over 12 months in comparison with Q3 ’21 year-over-year income development charges of plus 35%. On a constant-currency foundation, Q3 ’22 Clear Aligner revenues have been decreased by unfavorable overseas change of roughly $21 million or roughly 2.8% sequentially and roughly $47.4 million or roughly 6.1% 12 months over 12 months. For the quarter, Q3 Aligner volumes replicate a sequential enhance in Invisalign shipments from Asia Pacific and Latin America, in addition to North America Invisalign teen instances offset by decrease quantity in EMEA and North America, primarily Invisalign grownup instances.
For Q3, Invisalign First for youths as younger as six grew 12 months over 12 months and was sturdy throughout all areas. On a trailing 12-month foundation, as of Q3, Invisalign Clear Aligner shipments for teenagers and younger youngsters utilizing Invisalign First up 12 months over 12 months to over 734,000 instances. For Q3, the full variety of new Invisalign-trained medical doctors elevated sequentially 8.5% pushed by North America and Asia Pacific. When it comes to Invisalign submitters, the full variety of medical doctors shipped to for Q3 elevated sequentially to 84,400 medical doctors, the second highest quantity this 12 months, pushed by Asia Pacific and the Americas.
From a channel perspective, ortho submitters have been barely, 12 months over 12 months, up, particularly from medical doctors submitting teen instances, offsetting — offset by a number of GP dentists 12 months over 12 months, particularly in EMEA. For different noncase revenues, which embody retention merchandise akin to Vivera retainers, medical coaching and schooling, equipment, e-commerce, and our new subscription packages akin to our DSP, Q3 revenues have been up each sequentially and 12 months over 12 months. This displays sturdy development in retainers sequentially and year-over-year development throughout all areas, pushed by extra submitters. In U.S., revenues for our physician subscription program elevated sequentially and 12 months over 12 months.
I am more than happy to see continued momentum in noncase revenues pushed by subscription-based packages that we count on to proceed to develop throughout the enterprise. Now let’s flip to the specifics across the third quarter outcomes, beginning with the Americas. The Q3 Invisalign case volumes for Americas have been down sequentially single-digit percentages and primarily as a consequence of decrease Invisalign bulk shipments. The surroundings stays difficult and suggestions from our clients signifies client financing and affected person no-shows affecting their practices in Q3, particularly with grownup sufferers.
Q3 Invisalign quantity additionally displays elevated case submissions from orthodontic channel and sequential development within the teen section. For Q3, teen sufferers have been most resilient, reflecting continued momentum in youthful sufferers with Invisalign First, in addition to the brand new Invisalign Teen case pack. Throughout Q3, Invisalign Teen case packs grew each sequentially and 12 months over 12 months. As a reminder, Invisalign Teen case packs, a brand new subscription program that permits orthodontists to purchase clear aligners and packs upfront.
Additionally they embody unique apply improvement advantages with the Invisalign model and require an incremental quantity dedication from medical doctors. Teen case packs are at present out there within the U.S., Canada, and France, and we count on to be expanded extra in EMEA area. Turning to our worldwide enterprise for Q3, Invisalign Clear Aligner quantity was down very barely sequentially, 1.4%, with sturdy sequential development for APAC, offset by decrease quantity in EMEA. For EMEA, Q3 working surroundings was difficult.
Inflation within the Eurozone is greater than 10% and international macroeconomic components weighed on client sentiment and buying choices, particularly for grownup sufferers, which compounded the impression of Q3 summer season seasonality. Much like the Americas, medical doctors in EMEA additionally reported elevated appointment cancellations and the impression of much less sufferers financing their purchases. EMEA teen sufferers additionally resilient in Q3 elevated sequentially in Iberia, in addition to France, the place we launched teen case packs throughout the quarter. In APAC, Q3 sequential development was led by China, Japan, and ANZ regardless of ongoing COVID restrictions and lockdowns in components of China and Japan.
On a year-over-year foundation, Invisalign case volumes mirrored elevated shipments throughout nearly all markets, led by Taiwan, Thailand, India, and Korea, pushed by elevated submitters. In Q3, APAC sequential development additionally displays sturdy demand from our expanded Invisalign clear aligner product portfolio in China. Recall in late April, Q2, we launched two new merchandise that higher serve the increasing market in China. Invisalign Grownup and Invisalign Normal clear aligners leverage our confirmed know-how whereas broadening our attraction to extra client segments.
Q3 was the primary full quarter providing these new merchandise that present medical doctors and sufferers in China with broader medical and reasonably priced choices for reasonable to advanced grownup instances. Lastly, I am happy to share that the Invisalign system was not too long ago awarded the Good Design Award for 2022, making it the primary orthodontic equipment to win the celebrated award in Japan. Within the choose’s evaluation of the Invisalign system, they emphasised that the chance for enamel straightening is excessive in Japan and cited the barrier to adoption by Japanese customers is resistance to metallic braces and praised the Invisalign system as an orthodontic answer that may enhance the standard of life throughout remedy. We definitely acknowledge the significance of the Japanese marketplace for digital orthodontics and is without doubt one of the causes we opened our first workplace in Tokyo practically 15 years in the past and established remedy planning operations in Yokohama a number of years in the past.
Turning to new improvements, we proceed to ship our know-how highway map. As I discussed earlier, throughout the quarter, we started to commercialize a number of new services that we beforehand introduced would come to market within the second half of 2022. These know-how developments illustrate our dedication to steady innovation in digital orthodontics, and we stay excited concerning the transformational tasks that we’re engaged on as we proceed to drive the evolution of our trade. No different dental firm has the expertise, together with over 14 million sufferers handled to this point to steer the transformation of the apply of dentistry.
Our client advertising give attention to educating customers concerning the Invisalign system and driving that demand to Invisalign physician’s places of work in the end capitalize on the huge market alternative to rework 500 million smiles globally. In Q3, we constructed on our profitable Invis Is media marketing campaign and continued our launch of the Invis is Drama Free, focused at teenagers, and Invis When All the pieces Clicks, focused at adults. Our teen marketing campaign, Invis is Drama Free highlights the advantages of Invisalign whereas humorously juxtaposing them with the numerous trade-offs concerned with utilizing braces. Our Invis is When All the pieces Clicks marketing campaign showcases Invisalign remedy reworking smiles and the ensuing confidence it offers to younger adults.
Throughout Q3, we had over 4.3 billion impressions delivered in 14 million visits to our web site, a 1.6% year-over-year enhance on account of rightsizing our media investments. We’re additionally rightsizing our client media investments throughout all core EMEA markets, impacting the impressions and distinctive visits. In U.S., we continued our influencer and creator-centric campaigns, partnering with main smile squad creators like Olympic Gold Medalist, Suni Lee, Michael Le, Josh Richards, and Marsai Martin. Every of those creators shared their private expertise of Invisalign remedy and why they selected to rework their smile with Invisalign aligners.
Most not too long ago, Suni Lee shared her optimistic expertise with Invisalign in main media programming embody Good Morning America, individuals.com, leading to over 93 million impressions. We proceed to spend money on client promoting throughout APAC area, leading to a 72% year-over-year enhance in impressions and 29% year-over-year enhance in distinctive guests. Our ongoing campaigns have been omnipresent throughout the highest social media platforms akin to TikTok, Snapchat, Instagram, and YouTube to extend the attention of the Invisalign model with younger adults and teenagers. In Q3, we launched a world plot on the Roblox platform throughout the common recreation LiveTopia making a enjoyable expertise for gamers to find out about the advantages of Invisalign remedy.
To this point, we had over 5.9 million impressions delivered in over 2.6 million distinctive guests on the sport expertise. Adoption of My Invisalign Shopper and Affected person app continues to extend with 2.2-plus million downloads to this point. Utilization of our key digital instruments additionally continued to extend. Dwell replace was utilized by 41,000 medical doctors or greater than 395,000 instances, decreased time spent in modifying remedy by 18%.
Invisalign Follow app has been downloaded 314,000 occasions to this point. Additional, we acquired greater than 110,000 affected person photographs in our digital care functionality to this point, offering wealthy international information to leverage our AI capabilities and enhance our providers for medical doctors and sufferers. The investments that we make to drive affected person demand and conversion to assist our physician clients is unparalleled in our trade, leveraging the worldwide recognition of the Invisalign system. No different dental firm equals our model power right this moment.
For extra particulars on our client advertising packages, please see our Q3 ’22 earnings and convention slides. Turning to exocad. General, I am more than happy with our progress with the exocad enterprise and its management and restorative dentistry. Along with the iTero-exocad Connector, I discussed beforehand, throughout the quarter, we additionally launched iTero NIRI, NIRI is near-infrared know-how intraoral digicam photographs and are actually mechanically imported into dental CAD when designing restorations, enabling technicians to visualise the inner and exterior tooth construction and optimize the method of margin line tracing.
The brand new xSnap module is a mannequin attachment for a printable 3D articulated system, that includes a spherical head, which permits a exactly executed motion. And Ivoclar’s Ivotion Dental System, a whole workflow for digital manufacturing of high-quality detachable dentures is now out there on exocad. Collectively, the iTero and exocad product portfolios assist speed up the digital transformation of dental practices by facilitating the way in which medical doctors and labs collaborate to ship higher care for his or her sufferers. As a part of the Align Digital platform, the mixing of iTero’s digital scanning and exocad’s full software program answer delivers seamless end-to-end digital workflows from prognosis to remedy, planning, after which fabrication.
Prospects are already using the automated workflows, unlocking efficiencies and productivities, that are extra vital than ever within the present financial local weather. With the current integration of iTero NIRI and intraoral digicam photographs distinctive to iTero Ingredient 5D imaging techniques and exocad Rijeka software program launch, Align is redefining restorative visualization and remedy planning for the medical doctors and labs. We’re dedicated to persevering with and innovating within the dental trade to drive effectivity and medical excellence for the good thing about our clients and their sufferers. With that, I will now flip it over to John.
John Morici — Chief Monetary Officer
Thanks, Joe. Now for our Q3 monetary outcomes. Complete revenues for the third quarter have been $890.3 million, down 8.2% from the prior quarter and down 12.4% from the corresponding quarter a 12 months in the past. On a constant-currency foundation, Q3 2022 unfavorable overseas change decreased Q3 revenues by roughly $25.1 million sequentially and roughly $57.4 million 12 months over 12 months.
For Clear Aligners, Q3 revenues of $732.8 million have been down 8.2% sequentially primarily as a consequence of decrease volumes, unfavorable overseas change, increased promotions and reductions, and product combine shift, partially offset by increased further aligners. On a year-over-year foundation, Q3 clear aligner income have been down 12.5%, primarily reflecting the aforementioned objects, offset considerably by per-order processing charges and better noncase revenues. On a constant-currency foundation, Q3 ’22 unfavorable overseas change decreased Q3 Clear Aligner revenues by roughly $21 million or roughly 2.8% sequentially and roughly $47.4 million or roughly 6.1% 12 months over 12 months. For Q3, Invisalign ASPs for each complete and noncomprehensive remedy decreased sequentially and 12 months over 12 months.
On a sequential foundation, decline in ASPs replicate unfavorable impression from overseas change that Joe described earlier, in addition to increased reductions and product combine shift, partially offset by increased further aligners. On a year-over-year foundation, the decline in ASPs replicate the numerous impression of unfavorable overseas change, product combine shift, and better reductions, partially offset by the upper further aligners and per-order processing charges. As our revenues from subscription, retainers, and different ancillary merchandise proceed to develop and develop globally, a number of the historic metrics that focus solely on case shipments don’t account for our general development. In our earnings launch and monetary slides, you will note that we’ve got added our whole clear aligner income per case cargo which is extra indicative of our general development technique.
Clear aligner deferred revenues on the steadiness sheet elevated $37 million or 3.3% sequentially and $184 million or up 18.6% 12 months over 12 months and will probably be acknowledged as the extra aligners are shipped. Through the three months ended September 30, 2022, we acknowledged $137.2 million that was included within the clear aligner deferred income steadiness at December 31, 2021. The Q3 Techniques and Companies income of $157.5 million have been down 8% sequentially, primarily as a consequence of decrease scanner quantity, partially offset by increased providers revenues from our bigger put in base, and have been down 11.7% 12 months over 12 months primarily as a consequence of decrease scanner quantity and decrease ASP, partially offset by increased providers income from our bigger put in base. Q3 ’22, Techniques and Companies income have been unfavorably impacted by overseas change of roughly $4.1 million or roughly 2.5% sequentially.
On a year-over-year foundation, System and Companies revenues have been unfavorably impacted by overseas change of roughly $9.9 million or roughly 5.9%. Techniques and Companies deferred revenues on the steadiness sheet was up $4.1 million or 1.6% sequentially and up $76.5 million or 40.9% 12 months over 12 months, primarily as a result of enhance in scanner gross sales and the deferral of service revenues included with the scanner buy, which will probably be acknowledged ratably over the service interval. Through the three months ended September 30, 2022, we acknowledged $13.3 million that was included within the Techniques and Companies deferred revenues steadiness as of December 31, 2021. Shifting on to gross margin.
Third quarter general gross margin was 69.5%, down 1.4 factors sequentially and down 4.8 factors 12 months over 12 months. General gross margin was unfavorably impacted by roughly 0.8 factors sequentially and 1.8 factors on a year-over-year foundation as a result of impression of overseas change on our revenues. Clear Aligner gross margin for the third quarter was 70.9% down 2.4 factors sequentially as a consequence of decrease ASPs and elevated manufacturing spend as we proceed to ramp up operations at our new manufacturing facility in Poland. Clear Aligner gross margin for the third quarter was down 5.3 factors 12 months over 12 months as a consequence of elevated manufacturing spend for the explanations acknowledged beforehand, increased freight and a better mixture of further aligner quantity, and decrease ASPs.
Techniques and Companies gross margin for the third quarter was 63.3%, up 3.6 factors sequentially as a consequence of improved manufacturing absorption and decrease freight prices. Techniques and Companies gross margin for the third quarter was down 2.3 factors 12 months over 12 months as a consequence of increased stock prices and manufacturing inefficiencies coupled with decrease ASPs, partially offset by increased service revenues. Q3 working bills have been $475.5 million, down sequentially 4.8% and down 3.7% 12 months over 12 months. On a sequential foundation, working bills have been down $23.9 million, primarily as a consequence of managed spend on promoting and advertising as a part of our efforts to proactively handle prices.
Yr over 12 months, working bills decreased by $18.5 million for a similar causes as sequential, in addition to decrease incentive compensation. On a non-GAAP foundation, excluding stock-based compensation and amortization of acquired intangibles associated to sure acquisitions, working bills have been $443.4 million, down sequentially 4.8% and down 4.9% 12 months over 12 months. Our third-quarter working earnings of $143.7 million resulted in an working margin of 16.1%, down 3.3 factors sequentially and down 9.6 factors 12 months over 12 months. Working margin was unfavorably impacted by roughly 1.6 factors sequentially as a consequence of overseas change and decrease gross margin.
The year-over-year lower in working margin is primarily attributed to decrease gross margin, investments in our go-to-market groups and know-how, in addition to unfavorable impression from overseas change by roughly 3.5 factors. On a non-GAAP foundation, which excludes stock-based compensation and amortization of intangibles associated to sure acquisition, the working margin for the third quarter was 20.2%, down three factors sequentially and down 8.6 factors 12 months over 12 months. Curiosity and different earnings and expense web for the third quarter was a lack of $21 million, in comparison with a lack of $14.6 million in Q2 and an earnings of $0.8 million in Q3 of ’21 primarily as a consequence of bigger web overseas change losses from the weakening of sure foreign currency echange towards the U.S. greenback.
The GAAP efficient tax charge for the third quarter was 40.7% and in comparison with 35% within the second quarter and 30.9% within the third quarter of the prior 12 months. The third-quarter GAAP efficient tax charge was increased than the second-quarter efficient tax charge, primarily as a result of lower in earnings and modifications in jurisdictional mixture of earnings, leading to decrease tax advantages from overseas earnings tax at totally different charges and better than within the U.S. On a non-GAAP — our non-GAAP efficient tax charge was 33.1% within the third quarter in comparison with 25.6% within the second quarter and 22.2% within the third quarter of the prior 12 months. Third quarter web earnings per diluted share was $0.93, down sequentially $0.51 and down $1.35, in comparison with the prior 12 months.
Our EPS was unfavorably impacted by $0.30 on a sequential foundation and $0.48 on a year-over-year foundation as a consequence of overseas change. On a non-GAAP foundation, web earnings per diluted share was $1.36 for the third quarter, down $0.64 sequentially and down $1.51 12 months over 12 months. Shifting on to the steadiness sheet. As of September 30, 2022, money, money equivalents, and short-term and long-term marketable securities have been $1.1 billion, up sequentially $163.8 million and down $96.8 million 12 months over 12 months.
Of the $1.1 billion steadiness, $471 million was held within the U.S. and $670 million was held by our worldwide entities. Q3 accounts receivable steadiness was $859.6 million, down roughly 7.8% sequentially. Our general days gross sales excellent was 86 days, flat sequentially and up roughly 11 days as in comparison with Q3 final 12 months.
Money move from operations for the third quarter was $266.5 million. Capital expenditures for the third quarter have been $75.3 million, primarily associated to our continued investments to extend aligner manufacturing capability and services. Free money move, outlined as money move from operations much less capital expenditures, amounted to $191.1 million. We’re properly capitalized to proceed to take a position for development whereas managing by these difficult market situations, exiting the quarter with over $1 billion in money on the steadiness sheet and 0 debt.
Now, turning to full 12 months 2022 and the components that affect our views on our enterprise outlook. Underlying market dynamics, in addition to the reactions to macroeconomic headwinds by central banks, governments, and customers, stay unsure. We’ll proceed to give attention to these issues which were central to our traditionally profitable enterprise methods by managing these issues inside our management. This contains sustaining fiscal controls and targeted supply on our enterprise mannequin in order that we’re positioned for fulfillment as soon as the tough working surroundings in the end abates.
We stay assured within the big underpenetrated marketplace for the digital orthodontics and restorative dentistry, our know-how and trade management, and our means to execute and make progress towards our long-term mannequin of 20% to 30% income development. We count on to be under our fiscal 2022 GAAP working margin goal of 20%, which incorporates the impression from the present unfavorable overseas change of roughly two to 3 factors that was not factored into our working margin steering for the fiscal 12 months 2022 after we gave an replace on the Q1 ’22 earnings name in April. For 2022, we count on our investments in capital expenditures to exceed $300 million. Capital expenditures primarily relate to constructing building and enhancements, in addition to further manufacturing capability to assist our worldwide enlargement.
This contains our funding within the aligner fabrication facility in Wroclaw, Poland, which started servicing medical doctors within the second quarter of 2022. As well as, throughout This fall 2022, we count on to repurchase as much as $200 million of our widespread inventory by both — or a mixture of open market repurchases or an accelerated inventory repurchase settlement. With that, I will flip it again over to Joe for remaining feedback. Joe?
Joe Hogan — President and Chief Government Officer
Thanks, John. As we proceed to navigate a macroeconomic uncertainty, weaker client confidence, and the lingering impacts of COVID-19 shutdowns primarily in China and Japan, we stay targeted on our strategic initiatives, in addition to the unimaginable market alternative for digital dentistry and our merchandise. We consider our unwavering drive to rework smiles and alter lives for tens of millions of individuals around the globe is on one different clear aligner firm can match and positions us to raised deal with this market alternative. Whatever the working surroundings, we’re dedicated to balancing investments to drive development and long-term strategic priorities that may rework the apply of dentistry and strengthen our enterprise.
These are unsure occasions. Each enterprise is being impacted by macroeconomic environmental uncertainty. As well as, as a multinational firm primarily based in the USA with roughly half of our gross sales exterior the nation, the adverse impression from unfavorable overseas change has been like something I’ve ever seen in my profession. We’ll proceed to spend money on digital options and demand creation to assist medical doctors and their sufferers.
We’re dedicated to doctor-directed care and reworking the trade collectively whereas working by these international macroeconomic challenges. Thanks to your time right this moment. We stay up for updating you on our subsequent earnings name. Now I will flip the decision over to the operator for questions.
Operator?
Questions & Solutions:
Operator
At the moment, we’ll be conducting a question-and-answer session. [Operator instructions] Our first query comes from Jason Bednar with Piper Sandler. Your line is now open.
Jason Bednar — Piper Sandler — Analyst
Yeah. Hey, everybody. Thanks for taking the questions right here. Joe, from what we have seen and heard available in the market, I feel it goes with out saying that month-to-month demand has simply been fairly uneven right here within the U.S.
I feel July and September have been fairly darn gentle; August, perhaps not as weak however nonetheless not nice. I suppose did you see an analogous degree of uneven demand after we look exterior the U.S.? And I suppose is there something you’d name out geographically or in any of your channels that was perhaps much less unhealthy than what you have been ready for 3 months in the past?
Joe Hogan — President and Chief Government Officer
Jason, we began with not excessive expectations, to start with, all proper? However I might say the U.S. market panned out the way in which we thought general, perhaps a bit of extra power in Latin America, a bit of momentum regardless of the elections and a few economics there. Europe simply wasn’t fairly as sturdy as what we thought. And as we tried to clarify in my notes that I actually really feel it is simply — it is the uncertainty that circulates Europe proper now and Ukraine scenario would not assist both.
From an Asia standpoint, we’re affected by COVID once more. We noticed it in China, despite the fact that we had development in China, which was respectable, and in Japan additionally, however we noticed the market impression in these two areas, too. I felt nice about it is a smaller a part of the enterprise, however Korea, Taiwan, Thailand, and different companies that have been up considerably, however our main three have been nonetheless affected, primarily the three is Australia and China, and Japan with some COVID points. So, it is a approach of claiming, I feel normally, we anticipated the place we’re, we have been hoping for the perfect 12 months.
However what actually grabs me, too, Jason, perhaps I am supplying you with an excessive amount of to your name is that the teenager demand, we felt good about general throughout the globe in the USA, too. The teenager packs did properly general. And clearly, we’ll roll that out in different components of the world, too. The grownup — the impression on the grownup instances is what was — to me, is astounding within the sense, and also you see that move by the orthodontic neighborhood, the GP neighborhood, too.
And that is not simply in the USA, we see that everywhere in the world.
Jason Bednar — Piper Sandler — Analyst
OK. All proper. That is actually useful. And thanks for all that.
Perhaps Joe or John, simply on the margin subject, you’re backing away from that 20% margin flooring commentary that you simply had given beforehand. Absolutely understanding a part of that is FX associated. However perhaps are you able to speak about how a lot of it is tied to the decremental impression from decrease volumes. And you then absolutely perceive it is a robust macro surroundings to forecast.
However lots of traders proper now are actually attempting to get snug with how defensible margins and profitability are as we glance out to 2023, which I hope it isn’t, nevertheless it may very properly be one other robust 12 months for the enterprise simply given the worldwide macro surroundings we’re in. So, simply — are you prepared to offer any guardrails round what we are able to contemplate for 2023 margins? Or perhaps speak about how a lot flexibility you will have within the P&L to offset pressures from decrease volumes? Thanks.
Joe Hogan — President and Chief Government Officer
Jason, it is a honest query. Initially, I will flip it over to John, however I am the one which gave that 20% working margin piece. I had no concept you’d see worldwide forex swings and the way in which we have seen it. I have been in these jobs for a very long time, and you do not count on 25% decreases 12 months over 12 months in forex.
And so, clearly, we needed to again up on that piece. I be ok with the way in which we managed our price I be ok with the place we’re investing and the place we proceed to rightsize. John provides you with extra specifics.
John Morici — Chief Monetary Officer
So, on a constant-currency foundation, we count on to be at that 20% or above. It is — identical to Joe mentioned, it is fairly dramatic to see the FX modifications that we’ve got. As famous within the feedback, we mentioned it going to have an effect on the 12 months by two to 3 factors. So, there is not any — there is a dedication to that margin, and we’re investing primarily based on quantity that we see and different priorities that we’ve got on R&D and go-to-market actions and so forth.
Nevertheless it’s simply that FX piece that we’re calling out. However on a constant-currency foundation, we really feel that that variety of 20% nonetheless holds from earlier.
Jason Bednar — Piper Sandler — Analyst
OK.
Joe Hogan — President and Chief Government Officer
Thanks, Jason.
Operator
Our subsequent query comes from Brandon Vazquez with William Blair. Your line is now open.
Brandon Vazquez — William Blair and Firm — Analyst
Hey, guys, thanks for taking my query. I needed to go — I would like to return for a second sort of to the month-to-month development simply to — I feel what is likely to be useful to sort of perceive underlying market dynamics and perhaps you’ll be able to tease it out a bit of bit in Americas versus worldwide. Simply — what have been you seeing by the quarter whenever you — did you exit the quarter and going into This fall, have been issues stabilizing? Have been they getting higher? Have been they getting worse? Any sort of colour you can provide us round what the scenario is like as we go ahead from Q3?
Joe Hogan — President and Chief Government Officer
Once more, like on the final name, Brandon, I feel it performed out the way in which our expectations, I feel have been formatted. We talked about teenagers within the third quarter. And clearly, that is teen season. That performed out properly from what we anticipated.
And as we talked about earlier than, we expect teenagers are considerably shielded — not fully however shielded from the financial surroundings due to the time window for remedy and fogeys that need to assist their teenagers by that complete course of. The grownup section was the — we noticed essentially the most volatility in for certain, each in the USA, Europe, and in Asia. It is onerous for me to inform you that we’re — there’s any sort of change from month to month or quarter to quarter. It was fairly constant from what we have seen.
John, would you add the rest?
John Morici — Chief Monetary Officer
I imply, that is how we noticed it.
Brandon Vazquez — William Blair and Firm — Analyst
OK. After which internationally, you guys sound fairly enthusiastic about sort of the brand new product launches inside China, particularly providing that new perhaps lower-tier product. Are you able to simply discuss a bit of bit about what you are seeing there? How sturdy has the restoration been in China? How a lot of that restoration has come from actually opening up the product portfolio there? And the way ought to that sort of proceed going ahead? Thanks.
Joe Hogan — President and Chief Government Officer
Thanks, Brandon. That is a great query. I imply, China is a vital marketplace for us. As we talked about on different calls, these tier 3 and tier 4 cities have been an vital goal for us.
We have identified for about two years, we’ve got a gap in our portfolio in these areas, notably with — we’ve got complete on prime, after which we’ve got a reasonable product between it. So, we introduced Invisalign Normal, Invisalign Grownup. And what this does is it simply helps us section the market. These will not be — they can not deal with — these merchandise can have — deal with instances like Invisalign First scan or mandibular development or a number of the refined instances we’ve got on the market.
We do not supply CBCT, five-minute ClinCheck, and people sort of issues round these merchandise, too. So, we tailor these merchandise for extra reasonable sorts of instances in these particular areas the place public hospitals have been sturdy. And we — actually good outcomes from the standpoint of what we noticed within the uptake that we noticed over this final quarter, and we’ll proceed with that technique. We be ok with it.
John Morici — Chief Monetary Officer
And it is about market enlargement there. We’re promoting to extra medical doctors than we have offered to previously with these merchandise. So, we’re actually attempting to seize extra of that market, as Joe mentioned, into tier 3, tier 4 cities, and we noticed good uptake from that. And it is one thing that we all know to go to the market and be capable to attain these potential clients.
These are the kinds of merchandise that we want.
Joe Hogan — President and Chief Government Officer
Yeah. So, Brandon, I feel truthfully, I really feel actually good about our positioning there. China did carry out properly from a quantity standpoint, and we’ll proceed to replace on progress.
Brandon Vazquez — William Blair and Firm — Analyst
Nice. Thanks.
Joe Hogan — President and Chief Government Officer
Thanks.
Operator
Our subsequent query comes from Jon Block with Stifel. Your line is now open.
Jon Block — Stifel Monetary Corp. — Analyst
Thanks, guys. Hey, Joe. Hey, John. Perhaps simply first one for me.
The 3Q ’22 ASP of $1,150 versus $1,220, so I am counting down 6% Q over Q. A few of that is FX, however I feel if I take a look at your feedback, it looks as if half of that 6% headwind is FX. And John, I do know you mentioned combine, however I am counting that teen was about 35% of your 3Q ’22 instances versus 30% of your 2Q ’22 instances and teenage is a excessive acuity complete ASP. I might suppose DSP can be serving to pull out a number of the decrease ASP instances as DSP ramps quarter in, quarter out.
So, are you able to simply assist me with the ASP motion, what else was it exterior of FX? And if it was combine, why combine primarily based on my teen commentary?
John Morici — Chief Monetary Officer
Yeah. I feel you’ve got hit the most important items, Jon. Once you take a look at it majority was FX. We noticed the greenback strengthening, that clearly hits our numbers.
And you then take a look at the opposite components, we do have a better proportion of juvenile within the third quarter, and that is a assist. We even have issues that we have achieved like we answered on the earlier name about combine in China and enlargement out, and there is offsets to that. Nevertheless it’s primarily FX, after which you will have some combine. However from a discounting standpoint, or different issues, there was actually no general change to how we have achieved stuff.
It is primarily the FX piece and the combo.
Joe Hogan — President and Chief Government Officer
Jon, one different factor so as to add to that, too, on the DSP program, we take a look at that as incremental, not as changing different enterprise that we have had previously. So, like we really feel good that is an enlargement play for us. And I feel you see that within the numbers, too.
Jon Block — Stifel Monetary Corp. — Analyst
OK. So, perhaps simply shortly on that final level, Joe. Query 1b can be, you do not actually suppose any instances are being pulled out of the case quantity quantity into DSP that is really having an incremental adverse impression to ’22? Do you suppose these are simply really largely incremental? That was 1b, simply to be clear.
Joe Hogan — President and Chief Government Officer
Yeah. You already know, I feel you be taught a enterprise, Jon, by no means be binary, both or. I would say the vast majority of these instances, when you take a look at it, we’re selecting up from an ortho standpoint, lots of retention we by no means had earlier than. We see orthos doing touch-up instances and all that may have been achieved in-house at occasions.
So, I am not saying that there is completely nothing that might transpose from one to a different, however I would say primarily, we’re taking a look at that as a development alternative for us.
Jon Block — Stifel Monetary Corp. — Analyst
OK, useful. After which the final query, and it is simply the place I battle essentially the most. I feel type of who cares, however my view on teen versus the way you guys have positioned it with all due respect. And I get the teenager 2Q to 3Q had a great sequential development charge, however the 1Q to 3Q, as a result of 2Q was weak, was really under pattern on a four-year common throwing out 2020.
And Joe, simply — if we are able to go down that highway a bit of bit extra, teen case vols have been nonetheless down 3% 12 months over 12 months. This complete story is about taking perhaps 200 bps of share yearly on this market. What do you suppose general teen case quantity was globally when you guys have been down 3%? And perhaps simply actually the questions on market share features and when you nonetheless really feel such as you’ve acquired the momentum there or if that has slowed as of late and what can reaccelerate it? Thanks to your time.
Joe Hogan — President and Chief Government Officer
Yeah. Jon, once more, that is a great query. I feel whenever you speak about first quarter to second quarter, the rhythm that we had there, keep in mind, the traditional rhythms we have seen on this enterprise is seasonality, we name it. We now have not seen that since actually 2019.
And so, we had muted alerts on teenagers by 2020, ’21. Simply — it wasn’t the identical. What I favored about — what I noticed within the third quarter was we noticed teenagers come again within the sense of in a sample of what you’d count on in teen season, Q3, This fall. It is too early for me to dig out the information and inform you how a lot share we’re gaining towards wires and brackets.
Nicely, Jon, we do not speak about quite a bit or merchandise like — and we highlighted it right here right this moment, whenever you take a look at the Invisalign First product line, we’re actually getting large outcomes on the market on younger sufferers, six to 9 years outdated, the part 1/part 2 therapies, the place usually the part 2 could be a lot much less in depth than what the part 1 was with wires and brackets. So, our totally different extension units, so we see a giant uptake in that product line from a teen standpoint. We see that as penetration too. We have seen constant development from a share standpoint in these teen instances in Americas globally.
So, we simply launched curved wings mandibular development too that is having a very good begin available in the market, too, to handle some instances that mandibular development could not get previously. So, Jon, each with know-how, with our promoting campaigns, the teenager packs, and no matter, I proceed to be ok with our motion. We’ll have extra as we analyze the traits, the share traits, and stuff that we’ll be capable to share with you, however I do like our place within the market in teenagers.
Jon Block — Stifel Monetary Corp. — Analyst
Respect it. Thanks.
Joe Hogan — President and Chief Government Officer
Thanks, Jon.
Operator
Our subsequent query comes from Brandon Couillard with Jefferies. Your line is now open.
Brandon Couillard — Jefferies — Analyst
Hey, Joe.
Joe Hogan — President and Chief Government Officer
Hello, Brandon.
Brandon Couillard — Jefferies — Analyst
Only a query on simply opex and the way you are managing headcount, whether or not you pulled again in any components of the enterprise globally. And perhaps simply discuss concerning the levers that is likely to be at your disposal if the surroundings continues to deteriorate and perhaps if there are some areas that might be ring-fenced so far as the potential cuts.
Joe Hogan — President and Chief Government Officer
Brandon, it is Joe. Look, initially, what I defend with my life listed here are our direct salespeople and likewise our know-how and our engineering group and what we give attention to. And so, we have made certain that we proceed to bolster these. There’s simply different components of our enterprise, too, that we rightsized.
I imply, clearly, this enterprise is used to rising 20%, 30%. And so, we sort of got here into the 12 months with that mindset. We shortly realized it wasn’t and so we have taken actions as a way to try this. However you see that all through the enterprise.
Do not forget we even have actually sturdy productiveness packages, in manufacturing and all, that basically assist us throughout these occasions. Emory and his group do a terrific job, they assist to drive that. John provides you with one other perception in a way of how we’re managing opex throughout the enterprise.
John Morici — Chief Monetary Officer
So, we’ve got good perception into our P&Ls internationally. So, we’re taking a look at nation by nation in sure areas and so forth. And like Joe mentioned, from an general focus, we need to be sure that we’ll market and defending the gross sales, ensure our R&D know-how is placing out the perfect merchandise and the perfect know-how going ahead, so we defend that. After which we take a look at what bills make sense within the brief and long run in varied areas, varied campaigns that we’ve got to be sure that we’re getting the return that is applicable given the market situations.
So, we’re continuously iterating and altering issues, it is no totally different on the opposite aspect of issues. When a 12 months in the past, we have been trying on the development alternatives. We’re taking a look at it the identical kind of approach sort of on a country-by-country, market-by-market foundation is simply the opposite approach as it’s now. So, we really feel like we’ve got a great understanding of our return on funding and a great understanding of the levers that we have to pull or not pull given these situations.
Brandon Couillard — Jefferies — Analyst
After which, John, only one follow-up. Are you able to assist me simply sort of perceive what is going on on with the stock line and why that continues to develop 12 months over 12 months and sequentially? Is there one thing tied to the brand new European fab facility which may be driving that? And what we should always count on on that line within the subsequent few quarters?
John Morici — Chief Monetary Officer
Yeah. I feel we’re sort of attending to — we sort of get to a degree the place a few of that is because of simply the truth that you will have a 3rd manufacturing web site, and you are going to have uncooked supplies associated to that and different in-process stock and so forth there. So, you are going to have a few of that. A few of it’s also on the iTero aspect the place you are manufacturing and also you’re performing some issues the place you are securing provide.
I imply, there’s been lots of discuss and we be ok with our provide to have the ability to elements and so forth. We have bought a number of elements simply to be sure that we had ample provide for our forecast and so forth. However nothing out of the peculiar aside from some enlargement that we’ve got with new manufacturing after which ensuring that we secured our provide traces, and that is what we have seen in our numbers.
Brandon Couillard — Jefferies — Analyst
OK. Thanks.
Joe Hogan — President and Chief Government Officer
Thanks, Brandon.
Operator
Our subsequent query comes from Jeff Johnson with Baird. Your line is now open.
Jeff Johnson — Robert W. Baird and Firm — Analyst
Thanks. Good afternoon, guys. So, Joe, I need to pin you down a bit of bit on a few issues, if I may right here, that questions which were requested. And on the teenager packs particularly, I imply, look, we all know there have been so many grownup instances final 12 months with the [Inaudible] issue, no matter we need to name it, and stimulus spending and all that.
However the teen quantity is clearly the vital quantity. I feel we’re all attempting to give attention to right here. The down 3%, I feel, is what you mentioned 12 months over 12 months, up sequentially. That down 3% 12 months over 12 months on teen instances globally, I imply, how do you’re feeling like that compares to the general ortho market? Have been you higher or worse than different teen instances achieved with brackets and wires whenever you throw in different clear aligners from the rivals, issues like that? Simply how are you competing in that teen market proper now?
Joe Hogan — President and Chief Government Officer
Hey, Jeff, it is a honest query. I would first take it to Europe. I imply, Europe was down considerably for us, too. So, I do not suppose we have got a transparent sign out of there due to the economics and normally.
I imply, we did pretty properly in — from a European standpoint. However third quarter in Europe is rarely a very sturdy quarter, we’ll pull a sign out of. Once you take a look at the USA, you go to Gaidge information. And you will see that inside Gaidge Information aligners have been down, however Invisalign was really above what the generic aligners are reported in Gaidge information, which says we proceed to do properly with our teen portfolio and what we do.
You see wires and brackets instances really expanded. However what that’s, is you see in the event that they’re doing extra — fewer adults — and you understand how orthos have held on to teenagers for a very long time, you get a mixture phenomenon there the place it seems to be like they’re doing extra wires and brackets, however they are not. They’re simply doing fewer adults, and so they combine down in that sense. After which transfer over to Asia, I’ve all the time felt good about Asia is totally different by nation.
However the COVID overlay in Japan, particularly, but in addition China. I believed the teenager case quantity was nonetheless affordable. Nevertheless it’s nonetheless onerous to drag a sign out of lots of noise with the COVID shutdowns in all of these nations. So, once more, identical to in John’s query, Jeff, is I do really feel nice about our portfolio.
I be ok with how we’re positioning the product. I feel the teenager packs are a method to promote the way in which medical doctors need to commit on this space, I feel we’ll proceed to get sturdy there. The way forward for these teen instances, there is not any query it is digital. It is simply how we method it, the merchandise we launch, and convincing medical doctors an increasing number of that teenagers will use these and exhibiting them the outcomes that we’re seeing everywhere in the world.
Jeff Johnson — Robert W. Baird and Firm — Analyst
Yeah. Honest sufficient. All proper. After which I’ll jam two questions collectively, sort of as Jon Block right here, I would name it 2a and 2b and different separate questions.
However any replace on volume-based procurement in China, how we should always take into consideration that? After which I did not see a breakout for Americas versus worldwide medical doctors shipped to. You supplied that previously. Any approach we may get that quantity this time? Thanks.
John Morici — Chief Monetary Officer
Nicely, on the physician shipped to, what we have achieved is consolidated them collectively to a complete. And what we noticed, when you checked out worldwide versus home, they’re each up. And the numbers that we had — that is really our second highest ever from a shipped-to standpoint. However we determined to consolidate these collectively, with out giving an excessive amount of extra particulars on that.
However they’re each up.
Jeff Johnson — Robert W. Baird and Firm — Analyst
Is that sequentially, John, simply to be clear?
John Morici — Chief Monetary Officer
Sure. Sure.
Jeff Johnson — Robert W. Baird and Firm — Analyst
John, each up sequentially. Sorry, Joe.
John Morici — Chief Monetary Officer
Sure, sure, right.
Joe Hogan — President and Chief Government Officer
Yeah. On sequential, sure. on the volume-based buying in China, we’ve got our eyes throughout it, Jeff, as you’ll be able to guess. It represents anyplace between 15% and 18% of our enterprise there.
The best way they’re setting this up, just about in what we recall, in not our most important areas in the place we do enterprise in China. I feel we have positioned ourselves for this. Strategically, I really feel we are able to make the best transfer right here. Look, I’ve pals and different medical machine companies, I used to be within the medical units for some time.
We all know what this did to stents and hip transplants and various things. I really feel like the way in which they set this up, one is 70% of will probably be DBP in these areas, 30% will nonetheless be as much as the medical doctors within the sense of what they need to use and the way they need to use it. So, what’s key right here is that we train our portfolio and the capability that we’ve got over there to simply have a strategic positioning in that. So, I do not count on any main variations as we transfer into 2023.
We’ll simply have to attend to see how that goes. And as we transfer into 2024, 2025, how the federal government — which approach the federal government strikes.
Jeff Johnson — Robert W. Baird and Firm — Analyst
Thanks.
Joe Hogan — President and Chief Government Officer
Thanks.
Operator
Our subsequent query comes from Elizabeth Anderson with Evercore ISI. Your line is now open.
Elizabeth Anderson — Evercore ISI — Analyst
Hello, guys. Thanks a lot for the query. I suppose my first query is simply on gear line. I seen you type of speaking extra about leased gear within the quarter.
Are you able to type of speak about how that is been rising and type of what contribution that made to the gear revenues within the quarter?
John Morici — Chief Monetary Officer
Sure, I can begin with that. It is clearly a method that we’ve got. We have nice gear, nice merchandise, and we would like to have the ability to get these to our clients in a approach that they need to purchase. Generally these medical doctors of ours do not essentially need to buy it outright.
They need to strive different issues. And so, we have examined in sure markets, simply alternate options, sort of the rental mannequin and so forth. And we see good uptake. We see them these medical doctors now desirous to get a scanner to have the ability to digitize their apply.
So, it is actually at early stage proper now, Elizabeth, however it’s one thing that after we take into consideration how we need to go to market, we need to supply alternate options akin to leasing or increasing rental or different components of our enterprise are going to see the licensed preowned the place you will have upgrades and different issues that occur as we’ve got a bigger and bigger put in base, we’ll get a few of that gear again. We would like to have the ability to have a mechanism to have the ability to use that gear, use it somewhere else, and provides our clients alternate options, each by way of the gear that they will buy from us after which how they buy and use that gear from a financing or perhaps leasing or rental choices. And we expect that they’re going to find yourself utilizing our gear an increasing number of. After which we all know that helps from a digital standpoint once they use their gear, after which they’re going to find yourself utilizing extra Invisalign.
So, all of it sort of works from an ecosystem standpoint.
Elizabeth Anderson — Evercore ISI — Analyst
Bought it. After which simply by way of on the P&L, like one of many issues that, clearly, noticed the change in SG&A spend within the quarter and the way you pulled again on spending there. What about on the R&D line? Do you type of see a chance to drag again on R&D as properly going ahead? Or is that one thing you are type of keener to defend going ahead?
Joe Hogan — President and Chief Government Officer
Elizabeth, it is Joe. We need to defend R&D. Crucial a part of the enterprise. You may see the packages are rolling out.
The packages we’re rolling out, we did not do them this 12 months, proper? A few of these are three-year-old packages that we have been engaged on. And so, I do not need to cease the momentum on these. I imply, clearly, we’ll take any steps right here to protect the money move and integrity of this enterprise that we’ve got to do. However our entrance traces are our gross sales group and know-how.
And earlier than we go anyplace close to these, we need to ensure we do every little thing we are able to, then rightsize the enterprise in different areas.
Elizabeth Anderson — Evercore ISI — Analyst
Bought it. After which simply by way of my 2b query, by way of like what you are seeing by the month of October to date, if we’re type of fascinated about how the cadence of 4Q is shaping up, would you then count on just like the instances to be type of flat sequentially at this level primarily based on what you are seeing? Or like how can we take into consideration type of the place we are actually?
Joe Hogan — President and Chief Government Officer
You already know, sort of anticipating that query is, we’re not seeing any main change, I would say, from the momentum that we noticed within the second quarter.
Elizabeth Anderson — Evercore ISI — Analyst
You imply the third quarter?
Joe Hogan — President and Chief Government Officer
I am sorry, third quarter. That is proper, a bit of bit, yeah.
Elizabeth Anderson — Evercore ISI — Analyst
Thanks. Respect it.
Joe Hogan — President and Chief Government Officer
Thanks.
Operator
Our subsequent query comes from Erin Wright with MS. The road is now open.
Erin Wright — Morgan Stanley — Analyst
Nice. Thanks a lot. So, how ought to we take into consideration underlying ASPs going ahead, excluding the FX dynamics from right here simply given a number of the combine dynamics you famous? And FX is FX, and that is comprehensible. But when we do proceed to see what we’re seeing by way of the macro surroundings, what can we take into consideration by way of trough margins from right here? And do you see a chance for a type of restoration close to time period? Or any type of margin enlargement? Something you can provide us on that entrance can be useful.
Thanks.
John Morici — Chief Monetary Officer
Yeah. Clearly — Erin, that is John. Clearly, gross margin, op margins is a major concern for us. We need to be sure that we handle issues appropriately.
From an ASP standpoint, take FX out of this and actually FX out of our margin as a result of it is onerous to a lot coming by from a P&L standpoint. However we’re all the time taking a look at productiveness to have the ability to assist drive the enterprise. And as we scale up Poland is a good instance, we’ll change into extra productive there, and that may assist our margin. It is sort of in our margins proper now as an impression, however it’s going to get higher over time by utilization.
We take a look at the know-how that we’ve got within the enterprise and what it means from an ASP standpoint. And our clients perceive that. There’s all the time going to be geographical combine shifts that occur. Sure components of the world are at totally different occasions all year long.
However I do not count on a dramatic shift in our general ASPs. Take FX out of it from an general ASP standpoint after which we’re actually targeted on what can we do to have a look at financial savings that assist us from a gross margin standpoint and see that. After which additionally on an op margin standpoint for all of the opex issues that we beforehand talked about.
Erin Wright — Morgan Stanley — Analyst
OK. Thanks. After which simply going again to Elizabeth’s query on the quarterly cadence. Simply within the teen market, particularly, what are you seeing by way of typical seasonality there? And did you see a few of that momentum persevering with right here into the fourth quarter in that exact section? Or how ought to we be fascinated about the quarter-to-quarter cadence given — relative to what you usually see from a seasonal standpoint.
Joe Hogan — President and Chief Government Officer
The teenager market, predominantly, if we take a look at the third quarter. Clearly, it bleeds some into the fourth quarter, no matter, however I would not take something we’re seeing proper now and venture it into the long run to vary what the traditional fourth-quarter sequence could possibly be. So, like I mentioned beforehand on the query so far as whenever you take a look at third quarter shifting within the fourth quarter, we’re not seeing any significant change a method or one other.
Erin Wright — Morgan Stanley — Analyst
OK. Thanks.
Joe Hogan — President and Chief Government Officer
Thanks.
Operator
Our subsequent query comes from Nathan Wealthy with Goldman Sachs. Your line is now open.
Nathan Wealthy — Goldman Sachs — Analyst
Hello. Thanks for the questions. Good afternoon. If I may return to margins for a minute.
You talked about not altering the goal for this 12 months on a constant-currency foundation. I suppose — if I may perhaps ask the query this manner, if we do not see additional modifications to FX or the sort of general demand surroundings, do you suppose the 16% margin that you simply noticed this quarter on a GAAP foundation is indicative of what we should always assume going ahead, once more, sort of — assuming no sort of modifications within the underlying surroundings?
John Morici — Chief Monetary Officer
I would not say — I would not take that. I feel after we’re speaking about for the complete 12 months, we’re sort of taking a look at sort of that on a constant-currency foundation, that 20%. And I feel Q3, you will have impacts with Poland start-up and another issues within the quarter which might be impacting that. However after we take a look at the 20% and what we have been calling earlier within the 12 months, we have been fascinated about that much less concerning the quarters, however on a — extra on a complete 12 months foundation on a constant-currency foundation.
Nathan Wealthy — Goldman Sachs — Analyst
OK. And the FX headwind for the 12 months on margins is that 2% to three%?
John Morici — Chief Monetary Officer
That is the way in which to have a look at it, Nate. It is — you understand, we’re sort of taking a look at — as finest as we are able to name it now, we’re sort of utilizing the newest FX charges that you’ve got now. It is as much as predict what is going on to occur within the subsequent two months. However when you took sort of at present and sort of what we have achieved all year long after which use the present FX charges, we expect that is a two- to three-point impression.
And with out that FX charges, we — our GAAP numbers would have been as much as 20%, like we known as.
Nathan Wealthy — Goldman Sachs — Analyst
OK. Thanks for that. If I may simply ask a fast follow-up. Joe, I feel you had famous much less willingness of customers to finance therapies in each the U.S.
and Europe. How huge is that as a % of case volumes by way of what’s usually financed? After which, you understand, how a lot particularly sort of how may this weigh on demand? And I suppose, larger image, are there methods sort of on this surroundings that you simply sort of see as sort of perhaps being finest in a position to stimulate demand simply by way of the way you may both assist clients or medical doctors on this surroundings?
Joe Hogan — President and Chief Government Officer
Yeah. Nathan, I feel what we gave you is mainly information that we obtain from {the marketplace}. It is what we’re listening to from orthodontists and dentists normally in remedy. We haven’t any quantification to say so many sufferers have been looking for funding, they did not get it or there’s so many losses in that sense.
That is just about listed because the explanation why sufferers have refused remedy or fascinated about remedy within the monetary issues of it. John, would you?
John Morici — Chief Monetary Officer
No, I feel you are all the time going to have a mixture of — some sufferers, they’re going to pay for all of it upfront. Some will finance both by the physician or some exterior group. And I feel you are continuously going to have that. We do suppose as a lot as we are able to with our medical doctors to provide them a number of the monetary flexibility, in order that as they perhaps have further phrases the place they pay us, the medical doctors, they will perhaps apply a few of that to their sufferers, and so they may help their sufferers as properly, handle a number of the money move.
So, we’re conscious of it. We do as a lot as we are able to. It is simply sort of on the market. And like Joe mentioned, we do not have a quantification of it, however in harder financial occasions, we all know that sufferers will probably be searching for totally different alternate options.
Joe Hogan — President and Chief Government Officer
And, you understand, the opposite a part of your query, Nate, about how can we assist accounts. We watch funds, we attempt to assist in that sense at occasions. We attempt to drive direct Invisalign docs to do lots of Invisalign. And clearly, our promoting is extraordinarily vital to them.
So, we’ve got our complete lead program to assist them drive these issues. We simply need to be as near our clients as potential as a result of they’re feeling what we really feel. And we’ve got sturdy relationships with lots of them, and so they’re a part of the household right here. And we work it nation by nation, physician by physician, area by area to see how we may help.
Nathan Wealthy — Goldman Sachs — Analyst
Thanks a lot.
Shirley Stacy — Vice President, Company Communications and Investor Relations
Operator, we’ll take yet one more query, please.
Operator
Our remaining query comes from Kevin Caliendo with UBS. Your line is now open.
Kevin Caliendo — UBS — Analyst
Thanks, and thanks for sneaking me in. I respect it. So could have discovered a bit of bit on the remark round October, saying that the momentum continued. If we take into consideration that, that was type of down 12%, proper, 12 months over 12 months.
I feel what we’re all searching for is we noticed instances flat Q1 to Q2. After which we noticed a step down in Q3 regardless of a stronger teen season. So, I feel what we’re all attempting to determine right here is adjusting for the third quarter power, seasonality in teen, when do you really count on to see stabilization globally in instances, that means both sequentially or year-over-year flatness? Like when do you really count on that that might occur?
Joe Hogan — President and Chief Government Officer
Kevin, it is Joe. Look, I feel we are able to sit right here and inform you I feel we’re in fairly unstable financial occasions. I can not inform you what the greenback goes to be in three months. I do not know what is going on to occur in Europe.
I do not know the way unhealthy COVID hits China. I do not know what it does in Japan. So, I do know precisely what you are asking for and each investor is asking for. And we would provide you with that information if we thought we had it, however we’re in such a unstable time proper now.
We’re simply working this factor from month to month. As I discussed, as we go into the fourth quarter, clearly, there is a rhythm between teenagers and adults from the third quarter to the fourth quarter. What I discussed from a continuation standpoint is we’ve not seen a lot of a change between the third and the fourth proper now as we transfer into it. That is about in addition to I can inform you of what we’re seeing and what we’re experiencing, attempting to forecast what is going on to occur towards the tip of the quarter, subsequent quarter, I can not try this.
I do not suppose anyone right here can.
Kevin Caliendo — UBS — Analyst
And if I can simply ask a follow-up. There’s been lots of speak about spending and margins in 20% and every little thing else. And traditionally, previously, you guys all the time simply invested to develop. Is it now given the uncertainty of every little thing that you simply’re simply going to handle by a margin or attempt to handle to the 20% margin ex FX? Or, I imply, is that the technique? Or is it nonetheless to attempt to get again to the — what you would wish to do usually to hit sure development targets that you’ve got had?
Joe Hogan — President and Chief Government Officer
It is a development enterprise, Kevin. If we had good financial occasions right here, I can inform you, we would be having a a lot totally different dialog. So, the problem with this enterprise is how are we accountable on price and clearly, a challenged demand surroundings, however to maintain this firm very sturdy as a result of when this market comes again, you simply return in historical past and have a look, it comes again, and it comes again onerous. And we have got to be sure that we’re in a great place to have the ability to subject that when it does happen.
So, you will see us be, what I name, fiscally accountable, however we’ll proceed to be sure that we make investments and make as many modifications as we are able to round totally different areas of opex however to guard these key areas the place our buyer interface and the event of our know-how. And really, the operations capability we want on this enterprise when this factor does convey again. And that is not simply in manufacturing aligners. That is in having the ability to service clients throughout the board.
So, you will see us steadiness that properly as we should always do from a management standpoint.
Shirley Stacy — Vice President, Company Communications and Investor Relations
Nicely, thanks, everybody, for becoming a member of us right this moment. We respect your time and stay up for talking with you at upcoming monetary conferences and trade conferences, together with the Ortho Summit in Las Vegas subsequent month. You probably have any additional questions or follow-up, please contact our investor relations group. Have an incredible day.
Operator
[Operator signoff]
Period: 0 minutes
Name individuals:
Shirley Stacy — Vice President, Company Communications and Investor Relations
Joe Hogan — President and Chief Government Officer
John Morici — Chief Monetary Officer
Jason Bednar — Piper Sandler — Analyst
Brandon Vazquez — William Blair and Firm — Analyst
Jon Block — Stifel Monetary Corp. — Analyst
Brandon Couillard — Jefferies — Analyst
Jeff Johnson — Robert W. Baird and Firm — Analyst
Elizabeth Anderson — Evercore ISI — Analyst
Erin Wright — Morgan Stanley — Analyst
Nathan Wealthy — Goldman Sachs — Analyst
Kevin Caliendo — UBS — Analyst
Extra ALGN evaluation
All earnings name transcripts
